Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome

E. Bojesen S, O. Ammerpohl, Andreas Weinhäusel, Oskar Athur Haas, H. Mettal, M. Bohle R, A. Borkhardt, U. Fuchs

Research output: Contribution to journalArticlepeer-review

Abstract

We report the isolation of the 5' flanking region of GRAF (GTPase regulator associated with the focal adhesion kinase), previously described as a putative tumour suppressor gene of acute myelogenous leukaemia and myelodysplastic syndrome, and demonstrate its promoter activity in reporter gene assays. Two putative protein-binding sites are identified of which one was sensitive to CpG methylation. The suppressed GRAF expression could be restored in leukaemia cell lines by treatment with a demethylating agent and an inhibitor of histone deacetylases. In contrast to normal tissues, which tested negative for GRAF promoter methylation, 11 of 29 (38%) bone marrow samples from patients with acute myeloid leukaemia or myelodysplastic syndrome were positive.
Original languageEnglish
Pages (from-to)323-332
Number of pages10
JournalBritish Journal of Cancer
Volume94
Publication statusPublished - 2006

Research Field

  • Not defined

Keywords

  • GRAF
  • AML
  • promoter methylation
  • MDS

Fingerprint

Dive into the research topics of 'Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome'. Together they form a unique fingerprint.

Cite this